Lukaska Strategy and Design
site map        glossary

ask your veterinarian about LTCI

*Lymphocyte T-Cell Immunomodulator has received a conditional license from the United States Department of Agriculture. Additional efficacy and
potency studies are in progress. LTCI is manufactured by T-Cyte Therapeutics, Inc. and is exclusively distributed by IMULAN BioTherapeutics, LLC.

IMULAN is focused
on providing innovative
solutions for complex
animal diseases.
Our policy is to provide
veterinarians access to
conditionally approved
products for diseases,
such as FeLV and FIV,
where no current
approved therapy
is available.

Lymphocyte T-Cell
Immunomodulator (LTCI)
is the first and only
approved treatment aid*
in the United States for
Feline Leukemia Virus
(FeLV) and Feline
Immunodeficiency Virus
(FIV) infections. Results
from clinical studies have
shown LTCI to have
positive benefits on the
health of cats infected
with FeLV and FIV.

Imulan Biotherapeutics Website
NEW : LTCI is
Precision Immune Therapies for Veterinary Medicine
home        company        FeLV / FIV treatment aid        pricing         news         contact  
Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV) is Now Treatable

Clean design and simple navigation helped cat owners and veterinarians
discover the first and only approved treatment aid in the United States for
two of the most common and fatal feline diseases.

VIEW SITE

l
l
l
l
l
l
l
l
l
l
l

privacy   |   site map